
1996-1998 Associate, Esche Schümann Commichau (Hamburg, Germany)
|
Client
|
Description
|
|
ArcLight Capital Partners
|
Acquisition of MYR Group, Inc.
|
|
Avnet, Inc.
|
Acquisitions of Savoir Technology Group, Inc. in 2000 and Kent Electronics Corporation in 2001; $425 million Securitization Facility in 2001 and 2002; issuance of $475 million in public debt in 2003.
|
|
Chiral Quest Corp.
|
Preferred stock venture capital financings in 2007 and 2008.
|
|
Danisco A/S
|
Sale of United States flavor business in 2007.
|
|
German Practice
|
Representation of German corporations in the United States - ARNO GmbH, Chelsea Art Museum (managed by German individual), Eppendorf AG, New Commercial Room GmbH, Sauer Maschinenbaugesellschaft mbH, Symrise Inc., Vacation Villas International GmbH; representation of U.S. Companies in connection with German aspects of M&A transactions
|
|
ICAP North America Inc.
|
Acquisitions of First Brokers Securities, Inc. and APB Financial LLC in 2002.
|
|
Orient-Express Hotels, Ltd.
|
$218 million IPO and NYSE listing; several equity offerings since 2002, including a $150 million public offering in May 2009.
|
|
Pall Corporation
|
Acquisition of Filtration and Separations Group from US Filter Corporation in 2002.
|
|
Pointer Telocations, Ltd.
|
$8.5 million PIPE in 2007.
|
|
R.M. Smythe & Co., Inc.
|
Sale of collectibles business to Spink & Son Limited in 2008.
|
|
Sea Containers Ltd.
|
Several equity offerings of 4.2 million shares on a continued or delayed basis in 2003 and 2004; high yield debt offering in the principal amount of $103 million in 2004.
|
|
Symrise Inc.
|
Acquisition of worldwide flavor and seasonings business of Chr. Hansen A/S in 2008.
|
|
Trinity Biotech plc.
|
Acquisitions of coagulation business (German aspects) and cardiac product line from Sigma Diagnostics, Inc. in 2002; issuance of $3.5 million convertible debt in 2002; issuance of $20 million convertible debt in PIPE deal in 2003; issuance of $22.5 million in equity and warrants in PIPE deal in 2004; acquisitions of Adaltis U.S., Inc. and Fitzgerald Industries International, Inc. in 2004; acquisitions of Research Diagnostics, Inc. and Primus Corporation in 2005; $25 million public equity offering in 2006; acquisition of worldwide coagulation products of bioMerieux, Inc for $52 million in 2006; acquisition of Cortex Biochem, Inc. business in 2007; $7 million public equity offering in 2008.
|
|
Vuance Ltd.
|
Acquisition of Security Holding Corp. in 2007.
|